Navigation Links
Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
Date:2/12/2009

RICHMOND, Va., Feb. 12 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals focused on niche markets with unmet medical needs, announced today that it has entered into a definitive agreement with Merck & Co., Inc. whereby Merck, through an affiliate, will purchase all assets related to Insmed's follow-on biologics platform. Under the terms of the agreement, Insmed will receive a total of $130 million for the assets. After fees, taxes and other costs related to the transaction, Insmed expects net proceeds of approximately $123 million as a result of this agreement.

As part of this transaction, Insmed will receive initial payments of up to $10 million for Insmed's lead follow-on-biologic candidates and the remaining balance upon closing of the transaction, which is targeted for March 31, 2009. These initial payments will allow the Company to maintain its normal business operations throughout the closing period without the need for dilutive financing.

Insmed's follow-on biologics assets include INS-19 and INS-20, whose development and commercial rights will now belong to Merck, as well as the Boulder, Colorado-based manufacturing facility. Merck intends to assume the facility's lease and ownership of all the equipment in the building. In addition, upon closing of the transaction, Merck intends to offer positions to employees of the Boulder facility. Insmed will retain its Richmond, VA corporate office, which houses its Clinical, Regulatory, Finance, and Administrative functions, in support of the continuing IPLEX(TM) program.

"We have long maintained that our follow-on biologics assets hold substantial value, and this agreement with Merck, one of the largest pharmaceutical companies in the world, is a testament to that value," said Dr
'/>"/>

SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference
2. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008
3. NASDAQs Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmeds Compliance Date to March 20, 2009
4. Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule
5. Insmed to Seek Shareholder Approval for Reverse Split
6. Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants
7. Insmed to Present at Biosimilars 2008 Conference
8. Insmed to Present at BioPharm Asia 2008 Conference
9. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
10. Insmed CEO to Present at Drug Discovery & Development Conference
11. Insmed to Host Second Quarter 2008 Conference Call

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., Gabon, December 2 , - "...lem and Heritage" , Coinciding with the I...he,Gabonese Republic is hosting an international c...feguarding biological resources in Africa. The,con...eaders, ministers,scientific experts, private com...
(Date:12/2/2009)...Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald...TC Bulletin Board: EMDY), a leading,producer and d...powder and,soybean products in China, today announ...g issue of US Food & Drink Executive, a quarte...cutives in the food and beverage industry. , ...
(Date:12/2/2009)... Dec. 2 According to the National ...mericans diagnosed with diabetes already have some...thy, damage to the retina caused by leaky blood ve...h diabetes and is one of the most feared diabetic ...atients who,ve had diabetes for 10 years or more w...
(Date:12/1/2009)... Dec. 1 Reportlinker.com announces... its catalogue: ,, Emerging Clinical Trial Loc...hanging healthcare and regulatory environment ,...Clinical-Trial-Locations---Eastern-Europe-Market-d...-environment.html ,, Over the last decade phar...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8
...s,Inc. (Nasdaq: RNVS ) announced today that its s...reement with Evotec AG (Frankfurt Stock Exchange:,...ay. The merger is,expected to close by May 5, 2008...g share of Renovis common,stock will be automatica...an American Depositary Share (ADSs) of Evotec, wit...
...roMetic Life Sciences Inc.,("ProMetic") (TSX:PLI) ...olders on Wednesday, May 7, 2008 at 10:30 a.m. (ED... ("Meeting") will be held at the Montreal,Museum o... in Montreal.,Points to be covered are:, - Items...ormation Circular - Corporate Presentations, ...
...unced Thursday,that a majority of the company,s sh...e joining the healthcare workflow technology compa...hirty years of executive experience to,Bio-Optroni... headquarters,in Rochester, NY. The company,s prod...ent and optimization solutions for hospitals, spec...
Other Biology Technology:Renovis Stockholders Approve Acquisition by Evotec 2Prometic provides information for its Annual and Special Meeting of Shareholders 2Former GE, Kodak and SGS Executive Dan Kerpelman to Join Bio-Optronics as President and CEO 2
(Date:12/2/2009)... Duke University Medical Center researchers have ...cancer glioma may be better able to resist radiati... signaling pathway in these cancer stem cells, the...diation in a laboratory experiment. , The work ...er stem cells resist the effects of radiation much...
(Date:12/2/2009)... are reporting the first identification of substan... that changes harmless marine bacteria into killer...s in ACS, Environmental Science & Technology , a ...es note that bleaching already has destroyed up to...ists are searching for ways to slow or stop the da...
(Date:12/2/2009)..., December 2, 2009 Commonly prescribed beta 2 adr...in pregnant women as well as pre-term labor may in... psychiatric pathology, cognitive problems and poo...to a new study published in the December 2009 issu...ogy . , Beta 2 adrenergic agonist drugs as a cla...
Breaking Biology News(10 mins):Discovery makes brain tumor cells more responsive to radiation 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma 12872 1New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma 12872 2The Other Cruciate Ligament 3A Newer Treatments for PCL Tears 50542 1The Other Cruciate Ligament 3A Newer Treatments for PCL Tears 50542 2The Other Cruciate Ligament 3A Newer Treatments for PCL Tears 50542 3New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 1New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 2New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 3New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 4New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 5New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 6New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 7
...d tool to combat the worsening malaria epidemic in...leagues (from the Institut Pasteur in Paris) have ... on MSP3, a protein present on the surface of the ..., As the researchers report in the international ... the 30 healthy volunteers who received the vaccin...
...gist and flu expert is calling for mandatory vacci...s of protecting patients and hospital staff from w... by other United States researchers show that volu...at each year, nearly 40,000 Americans die from inf... immune systems that cannot readily fend off the d...
...s week in Nature shows for the first time that a m...ock cells that regulate daily activity of Drosophi...of neurons control morning and evening activity an...plunged into darkness for extended periods of time...rning to the evening cells and maintains a 12-hour...
Other Biology News:Johns Hopkins flu expert calls for mandatory vaccination of health care workers 2Johns Hopkins flu expert calls for mandatory vaccination of health care workers 3A resetting signal keeps circadian rhythm on track in Drosophila fruit flies 2
...c Nebulizers are available in two product models -...hese two models is that the 6000AT+ includes a mem...rier aerosol for improved detection limits and red...ection limits for a range of elements by 10-40 tim...
AMV RT HC 600 U from Invitrogen
T4 DNA Ligase; (1 x 103 U/ml) or (5 x 103 U/ml) supplied with 10x ligation buffer that includes ATP from Roche Applied Science
...lyzes the formation of a phosphodiester bonds betw... nicked duplex DNA molecules or between oligonucle...rand at 45 - 65?. Tfi DNA Ligase is stable and act...DNA ligases, Thus, Tfi DNA Ligase is the ideal enz...
Biology Products: